Literature DB >> 7149813

The use of a selective beta-adrenergic receptor blocker for the preoperative preparation of thyrotoxic patients.

P Dial, P R Hastings.   

Abstract

Metoprolol, a cardioselective beta-blocker, was used in two asthmatic, thyrotoxic patients in preparation for thyroidectomy. Adequate reduction in resting heart rate was achieved in both individuals without inducing clinically significant airway obstruction. Beta-1-blockade can be selectively employed in this clinical setting, but patients should be hospitalized and closely monitored for adverse effects on pulmonary function. Metoprolol therapy in patients with reversible airway obstruction is discussed with reference to recent studies on relative cardioselectivity.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7149813      PMCID: PMC1352975          DOI: 10.1097/00000658-198212001-00002

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  25 in total

1.  Comparison of effects of metoprolol and propranolol on asthmatic airway obstruction.

Authors:  C Skinner; J Gaddie; K N Palmer
Journal:  Br Med J       Date:  1976-02-28

2.  The effect of metoprolol --a new selective adrenergic beta1-receptor blocking agent-- in mild hypertension.

Authors:  C Bengtsson
Journal:  Acta Med Scand       Date:  1976

3.  Asthma and hyperthyroidism.

Authors:  G A Settipane; E Schoenfeld; M W Hamolsky
Journal:  J Allergy Clin Immunol       Date:  1972-06       Impact factor: 10.793

4.  Effect of adrenergic receptor blockade of the tachycardia of thyrotoxicosis and anxiety state.

Authors:  P Turner; K L Granville-Grossman
Journal:  Lancet       Date:  1965-12-25       Impact factor: 79.321

5.  Controlled trial of propranolol in thyrotoxicosis.

Authors:  R G Shanks; D R Hadden; D C Lowe; D G McDevitt; D A Montgomery
Journal:  Lancet       Date:  1969-05-17       Impact factor: 79.321

6.  The use of propranolol in the surgical treatment of thyrotoxic patients.

Authors:  T C Lee; R J Coffey; J Mackin; M Cobb; J Routon; J J Canary
Journal:  Ann Surg       Date:  1973-06       Impact factor: 12.969

7.  Reserpine in thyrotoxic crisis.

Authors:  P T Dillon; J Babe; C R Meloni; J J Canary
Journal:  N Engl J Med       Date:  1970-11-05       Impact factor: 91.245

8.  Thyroid disease and asthma.

Authors:  R K Bush; E N Ehrlich; C E Reed
Journal:  J Allergy Clin Immunol       Date:  1977-05       Impact factor: 10.793

9.  An eighteen months' study of the clinical response to metoprolol, a selective beta1-receptor blocking agent, in patients with angina pectoris.

Authors:  M B Comerford; E M Besterman
Journal:  Postgrad Med J       Date:  1976-08       Impact factor: 2.401

10.  Propranolol in the surgical management of thyrotoxicosis.

Authors:  P D Bewsher; C A Pegg; D J Stewart; D A Lister; W Michie
Journal:  Ann Surg       Date:  1974-11       Impact factor: 12.969

View more
  2 in total

Review 1.  Use of beta-adrenoceptor blocking drugs in hyperthyroidism.

Authors:  J Feely; N Peden
Journal:  Drugs       Date:  1984-05       Impact factor: 9.546

2.  The selective beta 1-blocking agent metoprolol compared with antithyroid drug and thyroxine as preoperative treatment of patients with hyperthyroidism. Results from a prospective, randomized study.

Authors:  A Adlerberth; G Stenström; P O Hasselgren
Journal:  Ann Surg       Date:  1987-02       Impact factor: 12.969

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.